Trial Profile
A Multi-database, Cohort study to evaluate the risk of age-related macular degeneration and cataract associated with Denosumab versus Zoledronic acid treatment in Osteoporosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 06 Feb 2020 Results (n=50821 denosumab and n=67471 zoledronic acid initiators) of large population cohort study were published in the Drugs and Aging
- 21 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management